As official media partners, VJHemOnc is thrilled to present updates from the 46th Annual Meeting of the European Group for Blood and Marrow Transplantation (EBMT).

This year’s meeting shed light on the latest research and education in hematological transplantation and cellular therapies.

View all videos

EBMT 2020

The 46th Annual Meeting of the European Group for Blood and Marrow Transplantation (EBMT) 2020
29 August - 1 September, 2020
VJHemOncVJHemOnc@VJHemOnc·
1h

ANCHOR & LIGHTHOUSE: melflufen-based combinations in R/R #Myeloma, w/ @OcioEnrique (@HematValdecilla): http://ow.ly/DOWZ50EJ8Tr

@COMyCongress #COMy21 #HemOnc #MultipleMyeloma #MMSM #ImmunoOnc #CTSM #TrialUpdate

Reply on Twitter 1392385320889602048Retweet on Twitter 13923853208896020481Like on Twitter 13923853208896020482Twitter 1392385320889602048
VJHemOncVJHemOnc@VJHemOnc·
15h

Latest updates in #CLL from the European Research Initiative on CLL (ERIC), w/ Paolo Ghia of @SanRaffaeleMI: http://ow.ly/rRap50EJ8Rk

#HemOnc #Leukemia #Leusm #CLLsm #COVID19 #CTSM #TrialUpdate

Reply on Twitter 1392173952710156288Retweet on Twitter 1392173952710156288Like on Twitter 13921739527101562881Twitter 1392173952710156288
Retweet on TwitterVJHemOnc Retweeted
tobyeyre82Toby Eyre@tobyeyre82·
22h

Anthracycline Treatment, Cardiovascular Risk Factors and the Cumulative Incidence of Cardiovascular Disease in a Cohort of Newly Diagnosed Lymphoma Patients from the Modern Treatment Era https://onlinelibrary.wiley.com/doi/10.1002/ajh.26230#.YJpgCanyh1M.twitter

Reply on Twitter 1392068086501625858Retweet on Twitter 139206808650162585821Like on Twitter 139206808650162585852Twitter 1392068086501625858
VJHemOncVJHemOnc@VJHemOnc·
18h

🚨 The women in science #MDS session is 2 hours away w/ Valeria Santini, Eva Hellström-Lindberg and Amer Zeidan @ 19:00 CEST/13:00 EDT 🚨

Register now! 👉http://ow.ly/fiV750EyV7P👈

@VJHemOnc #VJSessions #MDSsessions #HemOnc #MDSsm #AMLsm #CTsm

Reply on Twitter 1392133106245775366Retweet on Twitter 13921331062457753661Like on Twitter 13921331062457753663Twitter 1392133106245775366
VJHemOncVJHemOnc@VJHemOnc·
22h

The Myeloma Sessions with @VJHemOnc: post-COMy session on treating elderly patients with #Myeloma

Featuring expert debates on new data, optimal treatments and remaining questions!

Register now to get involved:
👉http://ow.ly/oHmD50EGlWV👈

#MMSM #HemOnc #COMy21 #VJSessions

Reply on Twitter 1392065713553264640Retweet on Twitter 13920657135532646401Like on Twitter 13920657135532646403Twitter 1392065713553264640
Load More...

EBMT 2020

The 46th Annual Meeting of the European Group for Blood and Marrow Transplantation (EBMT) 2020
29 August - 1 September, 2020

As official media partners, VJHemOnc is thrilled to present updates from the 46th Annual Meeting of the European Group for Blood and Marrow Transplantation (EBMT).

This year’s meeting shed light on the latest research and education in hematological transplantation and cellular therapies.

View all videos
VJHemOncVJHemOnc@VJHemOnc·
1h

ANCHOR & LIGHTHOUSE: melflufen-based combinations in R/R #Myeloma, w/ @OcioEnrique (@HematValdecilla): http://ow.ly/DOWZ50EJ8Tr

@COMyCongress #COMy21 #HemOnc #MultipleMyeloma #MMSM #ImmunoOnc #CTSM #TrialUpdate

Reply on Twitter 1392385320889602048Retweet on Twitter 13923853208896020481Like on Twitter 13923853208896020482Twitter 1392385320889602048
VJHemOncVJHemOnc@VJHemOnc·
15h

Latest updates in #CLL from the European Research Initiative on CLL (ERIC), w/ Paolo Ghia of @SanRaffaeleMI: http://ow.ly/rRap50EJ8Rk

#HemOnc #Leukemia #Leusm #CLLsm #COVID19 #CTSM #TrialUpdate

Reply on Twitter 1392173952710156288Retweet on Twitter 1392173952710156288Like on Twitter 13921739527101562881Twitter 1392173952710156288
Retweet on TwitterVJHemOnc Retweeted
tobyeyre82Toby Eyre@tobyeyre82·
22h

Anthracycline Treatment, Cardiovascular Risk Factors and the Cumulative Incidence of Cardiovascular Disease in a Cohort of Newly Diagnosed Lymphoma Patients from the Modern Treatment Era https://onlinelibrary.wiley.com/doi/10.1002/ajh.26230#.YJpgCanyh1M.twitter

Reply on Twitter 1392068086501625858Retweet on Twitter 139206808650162585821Like on Twitter 139206808650162585852Twitter 1392068086501625858
VJHemOncVJHemOnc@VJHemOnc·
18h

🚨 The women in science #MDS session is 2 hours away w/ Valeria Santini, Eva Hellström-Lindberg and Amer Zeidan @ 19:00 CEST/13:00 EDT 🚨

Register now! 👉http://ow.ly/fiV750EyV7P👈

@VJHemOnc #VJSessions #MDSsessions #HemOnc #MDSsm #AMLsm #CTsm

Reply on Twitter 1392133106245775366Retweet on Twitter 13921331062457753661Like on Twitter 13921331062457753663Twitter 1392133106245775366
VJHemOncVJHemOnc@VJHemOnc·
22h

The Myeloma Sessions with @VJHemOnc: post-COMy session on treating elderly patients with #Myeloma

Featuring expert debates on new data, optimal treatments and remaining questions!

Register now to get involved:
👉http://ow.ly/oHmD50EGlWV👈

#MMSM #HemOnc #COMy21 #VJSessions

Reply on Twitter 1392065713553264640Retweet on Twitter 13920657135532646401Like on Twitter 13920657135532646403Twitter 1392065713553264640
Load More...

Watch all EBMT 2020 Videos

View all
10:00
Graft failure after unmanipulated haplo-HSCT with PT-Cy in AML
Annalisa Ruggeri • 26 Aug 2020
1:31
Autoimmune cytopenias following allo-HSCT
Carlo Dufour • 25 Aug 2020
6:51
Role of the EBMT registry on reporting CAR T-cell outcomes
Christian Chabannon • 31 Aug 2020

Multiple Myeloma

View all
5:51
Conditioning with bortezomib and melphalan in myeloma
Meral Beksac • 31 Aug 2020
4:25
Latest news in cellular therapies
Christian Chabannon • 1 Sep 2020
4:33
CMWP & EBMT report: allogeneic HCT outcomes in myeloma patients on renal replacement
Meral Beksac • 31 Aug 2020
3:01
Treatment approaches for ASCT-eligible myeloma patients in the frontline
Mohamad Mohty • 1 Sep 2020

Lymphoma

View all
5:01
PORTIA: tisagenlecleucel and pembrolizumab in R/R DLBCL
Edmund Waller • 23 Aug 2020
2:41
Gray zone lymphoma: pembrolizumab
Fernando Barroso Duarte • 20 Aug 2020

Leukemia

View all
4:36
AML haplo-HSCT outcomes
Ali Bazarbachi • 23 Aug 2020
3:06
CLL: the GREEN study
Véronique Leblond • 20 Aug 2020

Graft-versus-host disease

View all
6:15
Standardizing chronic GvHD grading and assessment
John Murray • 24 Aug 2020
2:56
Preventive and therapeutic interventions for the microbiota
Florent Malard • 24 Aug 2020
1:37
Transplantation: a holistic approach
Jaap Jan Boelens • 23 Aug 2020
3:35
Role of the microbiome in GvHD
Sara Deola • 30 Aug 2020

COVID-19

View all
3:58
Repurposing monoclonal antibodies in the face of the COVID-19 pandemic
Christian Chabannon • 1 Sep 2020
4:55
EBMT 2020: cellular therapy day
Annalisa Ruggeri • 31 Aug 2020
2:11
Impact of COVID-19 on transplantation
Per Ljungman • 20 Aug 2020
6:50
Spain & COVID-19: HSCT, CAR-T and clinical practice
Anna Sureda • 19 Aug 2020
VJHemOnc VJHemOnc is intended for Healthcare Professionals only

By choosing to continue, you are confirming that you are a healthcare professional

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter

Subscribe now
The content of VJHemOnc is intended for healthcare professionals